vs
Side-by-side financial comparison of COLLEGIUM PHARMACEUTICAL, INC (COLL) and PARK NATIONAL CORP (PRK). Click either name above to swap in a different company.
COLLEGIUM PHARMACEUTICAL, INC is the larger business by last-quarter revenue ($205.4M vs $168.3M, roughly 1.2× PARK NATIONAL CORP). PARK NATIONAL CORP runs the higher net margin — 25.3% vs 8.3%, a 17.1% gap on every dollar of revenue. On growth, COLLEGIUM PHARMACEUTICAL, INC posted the faster year-over-year revenue change (12.9% vs 2.2%). PARK NATIONAL CORP produced more free cash flow last quarter ($191.9M vs $122.4M). Over the past eight quarters, COLLEGIUM PHARMACEUTICAL, INC's revenue compounded faster (19.1% CAGR vs 4.9%).
Collegium Pharmaceutical, Inc. is a specialty pharmaceutical firm focused on developing and commercializing innovative, abuse-deterrent pain management therapies. Operating primarily in the U.S. market, it offers extended-release analgesics for chronic pain patients, serving providers across primary and specialty care segments.
National Retail Systems, Inc. (NRS) includes Keystone Freight Corp. & National Retail Transportation, Inc. (NRT). NRS is an asset based 3PL founded in 1952. It is headquartered in Lyndhurst, New Jersey, United States.
COLL vs PRK — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | ||
|---|---|---|
| Revenue | $205.4M | $168.3M |
| Net Profit | $17.0M | $42.6M |
| Gross Margin | 62.5% | — |
| Operating Margin | 29.6% | — |
| Net Margin | 8.3% | 25.3% |
| Revenue YoY | 12.9% | 2.2% |
| Net Profit YoY | 35.3% | 10.4% |
| EPS (diluted) | $0.48 | $2.62 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $205.4M | $168.3M | ||
| Q3 25 | $209.4M | $169.5M | ||
| Q2 25 | $188.0M | $168.7M | ||
| Q1 25 | $177.8M | $157.9M | ||
| Q4 24 | $181.9M | $164.7M | ||
| Q3 24 | $159.3M | $170.3M | ||
| Q2 24 | $145.3M | $157.7M | ||
| Q1 24 | $144.9M | $152.8M |
| Q4 25 | $17.0M | $42.6M | ||
| Q3 25 | $31.5M | $47.2M | ||
| Q2 25 | $12.0M | $48.1M | ||
| Q1 25 | $2.4M | $42.2M | ||
| Q4 24 | $12.5M | $38.6M | ||
| Q3 24 | $9.3M | $38.2M | ||
| Q2 24 | $19.6M | $39.4M | ||
| Q1 24 | $27.7M | $35.2M |
| Q4 25 | 62.5% | — | ||
| Q3 25 | 61.7% | — | ||
| Q2 25 | 57.7% | — | ||
| Q1 25 | 54.8% | — | ||
| Q4 24 | 54.0% | — | ||
| Q3 24 | 60.8% | — | ||
| Q2 24 | 62.5% | — | ||
| Q1 24 | 63.1% | — |
| Q4 25 | 29.6% | — | ||
| Q3 25 | 29.7% | 34.3% | ||
| Q2 25 | 18.7% | 35.2% | ||
| Q1 25 | 12.2% | 32.4% | ||
| Q4 24 | 20.9% | — | ||
| Q3 24 | 21.9% | 27.4% | ||
| Q2 24 | 32.7% | 30.6% | ||
| Q1 24 | 34.1% | 27.8% |
| Q4 25 | 8.3% | 25.3% | ||
| Q3 25 | 15.0% | 27.8% | ||
| Q2 25 | 6.4% | 28.5% | ||
| Q1 25 | 1.4% | 26.7% | ||
| Q4 24 | 6.9% | 23.5% | ||
| Q3 24 | 5.9% | 22.4% | ||
| Q2 24 | 13.5% | 25.0% | ||
| Q1 24 | 19.1% | 23.0% |
| Q4 25 | $0.48 | $2.62 | ||
| Q3 25 | $0.84 | $2.92 | ||
| Q2 25 | $0.34 | $2.97 | ||
| Q1 25 | $0.07 | $2.60 | ||
| Q4 24 | $0.36 | $2.38 | ||
| Q3 24 | $0.27 | $2.35 | ||
| Q2 24 | $0.52 | $2.42 | ||
| Q1 24 | $0.71 | $2.17 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | ||
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $386.7M | $233.5M |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $301.7M | $1.4B |
| Total Assets | $1.7B | $9.8B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $386.7M | $233.5M | ||
| Q3 25 | $285.9M | $218.9M | ||
| Q2 25 | $222.2M | $193.1M | ||
| Q1 25 | $197.8M | $237.6M | ||
| Q4 24 | $162.8M | $160.6M | ||
| Q3 24 | $120.0M | $201.7M | ||
| Q2 24 | $271.6M | $261.5M | ||
| Q1 24 | $318.0M | $306.1M |
| Q4 25 | $301.7M | $1.4B | ||
| Q3 25 | $274.8M | $1.3B | ||
| Q2 25 | $232.2M | $1.3B | ||
| Q1 25 | $234.4M | $1.3B | ||
| Q4 24 | $228.8M | $1.2B | ||
| Q3 24 | $234.3M | $1.2B | ||
| Q2 24 | $216.6M | $1.2B | ||
| Q1 24 | $222.2M | $1.2B |
| Q4 25 | $1.7B | $9.8B | ||
| Q3 25 | $1.6B | $9.9B | ||
| Q2 25 | $1.6B | $9.9B | ||
| Q1 25 | $1.6B | $9.9B | ||
| Q4 24 | $1.7B | $9.8B | ||
| Q3 24 | $1.6B | $9.9B | ||
| Q2 24 | $1.1B | $9.9B | ||
| Q1 24 | $1.1B | $9.9B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | ||
|---|---|---|
| Operating Cash FlowLast quarter | $123.0M | $198.3M |
| Free Cash FlowOCF − Capex | $122.4M | $191.9M |
| FCF MarginFCF / Revenue | 59.6% | 114.1% |
| Capex IntensityCapex / Revenue | 0.3% | 3.8% |
| Cash ConversionOCF / Net Profit | 7.25× | 4.65× |
| TTM Free Cash FlowTrailing 4 quarters | $327.6M | $328.2M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $123.0M | $198.3M | ||
| Q3 25 | $78.4M | $52.6M | ||
| Q2 25 | $72.4M | $49.7M | ||
| Q1 25 | $55.4M | $37.9M | ||
| Q4 24 | $84.6M | $178.8M | ||
| Q3 24 | $-9.0M | $43.8M | ||
| Q2 24 | $67.4M | $50.9M | ||
| Q1 24 | $61.9M | $35.0M |
| Q4 25 | $122.4M | $191.9M | ||
| Q3 25 | $78.3M | $51.1M | ||
| Q2 25 | $72.4M | $48.4M | ||
| Q1 25 | $54.6M | $36.8M | ||
| Q4 24 | $84.1M | $169.7M | ||
| Q3 24 | $-9.2M | $41.7M | ||
| Q2 24 | $67.1M | $49.0M | ||
| Q1 24 | $61.4M | $31.9M |
| Q4 25 | 59.6% | 114.1% | ||
| Q3 25 | 37.4% | 30.1% | ||
| Q2 25 | 38.5% | 28.7% | ||
| Q1 25 | 30.7% | 23.3% | ||
| Q4 24 | 46.2% | 103.0% | ||
| Q3 24 | -5.8% | 24.5% | ||
| Q2 24 | 46.2% | 31.1% | ||
| Q1 24 | 42.3% | 20.8% |
| Q4 25 | 0.3% | 3.8% | ||
| Q3 25 | 0.1% | 0.9% | ||
| Q2 25 | 0.0% | 0.8% | ||
| Q1 25 | 0.4% | 0.7% | ||
| Q4 24 | 0.3% | 5.6% | ||
| Q3 24 | 0.2% | 1.2% | ||
| Q2 24 | 0.2% | 1.2% | ||
| Q1 24 | 0.4% | 2.1% |
| Q4 25 | 7.25× | 4.65× | ||
| Q3 25 | 2.49× | 1.11× | ||
| Q2 25 | 6.05× | 1.03× | ||
| Q1 25 | 22.92× | 0.90× | ||
| Q4 24 | 6.75× | 4.63× | ||
| Q3 24 | -0.96× | 1.14× | ||
| Q2 24 | 3.44× | 1.29× | ||
| Q1 24 | 2.23× | 0.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.